Molecular genetics and targeted therapeutics in biliary tract carcinoma

doi:10.3748/wjg.v22.i4.1335

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12578)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

1152

WORD

360

HTML

6606

Figures (1-2)

312

Tables (1-4)

275

Sum=8705

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

476

Download

715

Sum=1191

Publishing Process of This Article

Item

Count

Browse

1238

Download

1444

Sum=2682

Jan 28, 2016 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (44)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Gastroenterol. Jan 28, 2016; 22(4): 1335-1347
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1335

Full Size Figure Download Figure

Figure 1 Molecular and genetic changes that occur during pathogenesis of malignant neoplasms in the biliary tract. BilIN: Biliary intraepithelial neoplasm; CIS: Carcinoma in situ; COX2: Cyclooxygenase 2; FHT: Fragile histidine triad; GB: Gall bladder; HER2: Human epidermal growth factor receptor 2; iNOS: Inducible nitric oxide synthase; IPNB: Intraepithelial papillary neoplasm of the bile duct; LOH: Loss of heterozygosity; MUC5AC: Mucin core protein 5AC.

Citation: Marks EI, Yee NS. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World J Gastroenterol 2016; 22(4): 1335-1347
URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1335.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1335